Inhibition of carbonyl reductase activity in pig heart by alkyl phenyl ketones

References

• Jakoby WB, Ziegler DM. The enzymes of detoxication. J Biol Chem 1990; 265: 20715–20718
   PubMed Web of Science ®Google Scholar
• Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem Pharmacol 1995; 49: 421–440
   PubMed Web of Science ®Google Scholar
• Oppermann UCT, Maser E. Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology 2000; 144: 71–90
   PubMed Web of Science ®Google Scholar
• Forrest GL, Gonzalez B. Carbonyl reductase. Chem Biol Interact 2000; 129: 21–40
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Shintani S, Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab Pharmacokinet 2006; 21: 1–18
   PubMed Web of Science ®Google Scholar
• Sawada H, Hara A, Nakayama T, Kato F. Reductases for aromatic aldehydes and ketones from rabbit liver. Purification and characterization. J Biochem (Tokyo) 1980; 87: 1153–1165
   PubMed Web of Science ®Google Scholar
• Ikeda M, Hattori H, Ohmori S. Properties of NADPH-dependent carbonyl reductases in rat liver cytosol. Biochem Pharmacol 1984; 33: 3957–3961
   PubMed Web of Science ®Google Scholar
• Imamura Y, Higuchi T, Nozaki Y, Sugino E, Hibino S, Otagiri M. Purification and properties of carbonyl reductase from rabbit kidney. Arch Biochem Biophys 1993; 300: 570–576
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hara A, Sawada H. Purification and characterization of a novel pyrazole-sensitive carbonyl reductase in guinea pig lung. Arch Biochem Biophys 1982; 217: 564–573
   PubMed Web of Science ®Google Scholar
• Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. J Biol Chem 1981; 256: 1206–1213, Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase
   PubMed Web of Science ®Google Scholar
• Iwata N, Inazu N, Takeo S, Satoh T. Carbonyl reductases from rat testis and vas deferens. Purification, properties and localization. Eur J Biochem 1990; 193: 75–81
   PubMedGoogle Scholar
• Usami N, Ishikura S, Abe H, Nagano M, Uebuchi M, Kuniyasu A, Otagiri M, Nakayama H, Imamura Y, Hara A. Cloning, expression and tissue distribution of a tetrameric form of pig carbonyl reductase. Chem Biol Interact 2003; 143–144: 353–361
   PubMed Web of Science ®Google Scholar
• Shimada H, Fujiki S, Oginuma M, Asakawa M, Okawara T, Kato K, Yamamura S, Akita H, Hara A, Imamura Y. Stereoselective reduction of 4-benzoylpyridine by recombinant pig heart carbonyl reductase. J Mol Catal B Enzym 2003; 23: 29–35
   Google Scholar
• Shimada H, Oginuma M, Hara A, Imamura Y. 9,10-Phenanthrenequinone, a component of diesel exhaust particles, inhibits the reduction of 4-benzoylpyridine and all-trans-retinal and mediates superoxide formation through its redox cycling in pig heart. Chem Res Toxicol 2004; 17: 1145–1150
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Felsted RL, Bachur NR. Mammalian carbonyl reductases. Drug Metab Rev 1980; 11: 1–60
   PubMed Web of Science ®Google Scholar
• Imamura Y, Nozaki Y, Higuchi T, Otagiri M. Reactivity for prostaglandins and inhibition by nonsteroidal anti-inflammatory drugs of rabbit liver befubolol reductase. Res Commun Chem Pathol Pharmacol 1991; 71: 49–57
   PubMedGoogle Scholar
• Imamura Y, Migita T, Uriu Y, Otagiri M, Okawara T. Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. J Biochem (Tokyo) 2000; 127: 653–658
   PubMed Web of Science ®Google Scholar
• Terada T, Niwase N, Koyama I, Imamura M, Shinagawa K, Toya H, Mizoguchi T. Purification and characterization of carbonyl reductases from bovine liver cytosol and microsomes. The cytosolic enzyme has a novel 3α/17β-hydroxysteroid dehydrogenase activity. Int J Biochem 1993; 25: 1233–1239
   PubMedGoogle Scholar
• Atalla A, Breyer-Pfaff H, Maser E. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamine-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica 2000; 30: 755–769
   PubMed Web of Science ®Google Scholar
• Hermans JJR, Thijssen HHW. The in vitro ketone reduction of warfarin and analogues. Substrate stereoselectivity, product stereoselectivity and species differences. Biochem Pharmacol 1989; 38: 3365–3370
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti M, Pianezzola E, Fraier D, Castelli MG, Dostert P. Stereoselectivity of idarubicin reduction in various animal species and humans. Xenobiotica 1991; 21: 473–480
   PubMed Web of Science ®Google Scholar
• Eyles DW, Pond SM. Stereospecific reduction of haloperidol in human tissues. Biochem Pharmacol 1992; 44: 867–871
   PubMed Web of Science ®Google Scholar
• Dow J, Berg C. Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs, and humans. Chirality 1995; 7: 342–348
   PubMed Web of Science ®Google Scholar
• Nagamine S, Horisaka E, Fukuyama Y, Maetani K, Matsuzawa R, Iwakawa S, Asada S. Stereoselective reductive metabolism of metyrapone and inhibitory activity of metyrapone metabolites, metyrapol enantiomers, on steroid 11β-hydroxylase in the rat. Biol Pharm Bull 1997; 20: 188–192
   PubMed Web of Science ®Google Scholar
• Rosemond MJC, Walsh JS. Human carbonyl reduction pathways and a strategy for their study in vitro. Drug Metab Rev 2004; 36: 335–361
   PubMed Web of Science ®Google Scholar